Polygonatum kingianum Graminans fructan as well as composition, preparation method and application thereof
By extracting and refining novel structures of Graminans fructans from the rhizomes of diamondine, the problem of difficult to study the biological efficacy of tannosaccharides is solved, the significant effect of the sugar in immunomodulation is achieved, and new health care and medicines are provided. application.
Patent Information
- Application Number
- CN202411148348.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-20
- Publication Date
- 2024-11-29
AI Technical Summary
The structural complexity and biological efficacy of polysaccharides are difficult to study in depth, and there is a lack of components with immunomodulatory activity.
A novel structure of diamond polygonatum Graminans type fructan was discovered and extracted. Graminans type fructans with a weight average molecular weight of 5kDa to 6kDa were isolated from the rhizomes of diamond polygonatum by extraction, grading alcohol precipitation and refining of warm or hot water. , the sugar is replaced by acetyl at the 2, 3 or 6 portion of the mannose residue, and has significant immunomodulatory ability.
The Graminans-type fructan can significantly promote the secretion of cytokines IL-6, TNF-α, etc. in RAW264.7 cells, and has the ability to regulate the body and provide new health care products and drugs application potential.
Smart Images

Figure CN119039472A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the fields of food and medicine, and in particular to a Polygonatum cyrtonema Graminans type fructan with a novel structure, a composition thereof, a preparation method and an application thereof. Background Art
[0002] Polygonatum sibiricum is a traditional Chinese herbal medicine. It is the dried rhizome of Polygonatum kingianum Coll.etHemsl., Polygonatum sibiricum Red. or Polygonatum cyrtonema Hua, which belongs to the Liliaceae family. It has the effects of nourishing qi and yin, strengthening the spleen, moistening the lungs and benefiting the kidneys. Polygonatum kingianum Coll.etHemsl. is a rhizome herbaceous plant of the genus Polygonatum in the Liliaceae family. It grows under forests, in bushes or on shady and wet grass slopes. It is often distributed in Guangxi, Sichuan, Guizhou, Yunnan and other places. Polygonatum sibiricum was first recorded in the "Famous Doctors' Records": "Polygonatum sibiricum: sweet, flat, non-toxic. It mainly nourishes the middle qi, eliminates rheumatism, and calms the five internal organs. Long-term use can make the body lighter, prolong life, and prevent hunger." It is listed as a top grade. "Modern Practical Chinese Medicine" also says: "It is a nourishing and strengthening medicine, effective for various weakness symptoms after illness. It is also an antipyretic, used for intermittent fever, gout, periostitis, etc. It is also an ascarid expelling medicine, and is also effective for high blood pressure."
[0003] According to research, the active chemical components of polygonatum sibiricum mainly include polysaccharides, flavonoids, saponins and lignans. Among them, polysaccharide compounds are the most common type of component in the chemical components of polygonatum sibiricum plants reported at home and abroad in recent years. Polysaccharide compounds are also important markers for identifying polygonatum sibiricum. The Chinese Pharmacopoeia stipulates that polygonatum sibiricum, calculated on a dry basis, must contain no less than 7.0% polygonatum polysaccharide. However, polysaccharides have extremely complex structures due to their large molecular weight, rich monosaccharide composition and substituents, and diverse glycosidic bond connection methods. It is extremely difficult to study the biological effects of polysaccharides and further research is urgently needed. The inventors have conducted systematic chemical, physical and pharmacological studies on Yunnan polygonatum sibiricum polysaccharides, and reported for the first time a novel Graminans-type fructan, and surprisingly found that the polysaccharide has immunomodulatory activity. Summary of the invention
[0004] The present invention is the first to discover a novel Graminans-type fructan in Polygonatum cyrtonema. The Graminans-type fructan has a chemical structure represented by the following general formula:
[0005]
[0006] In formula (1), n represents the number of sugar repeating units, and n is a natural number from 1 to 5; R represents an acetyl group (CH 3CO-), the sugar to which it is attached is mannose.
[0007] The weight average molecular weight of the Polygonatum cyrtonema Graminans type fructan of the present invention is 5kDa-6kDa, and the 2nd, 3rd or 6th position on the sugar ring of mannose is partially substituted by acetyl.
[0008] The inventors have found through activity studies that the Polygonatum cyrtonema Graminans-type fructan with the structure can significantly promote the secretion of cytokines such as IL-6, TNF-α and NO by RAW264.7 cells, thereby having the ability to regulate the body's immunity.
[0009] In order to obtain the Bletilla formosana Graminans-type fructan with novel structure and outstanding activity, the present invention also provides a method for separating and extracting the Bletilla formosana Graminans-type fructan from the rhizome of Bletilla formosana.
[0010] A method for preparing the Polygonatum cyrtonema Graminans type fructan of the present invention comprises the following steps:
[0011] Step 1: extracting a crude polysaccharide solution from the rhizome of Polygonatum cyrtonema with warm water or hot water;
[0012] Step 2: graded alcohol precipitation to obtain crude polygonatum odoratum polysaccharide;
[0013] Step 3: purify 60% of the alcohol precipitate in the crude Polygonatum cyrtonema polysaccharide to obtain the Polygonatum cyrtonema Graminans type fructan.
[0014] Furthermore, the preparation method of the Polygonatum cyrtonema Graminans type fructan of the present invention specifically comprises the following steps:
[0015] The above steps 1 and 2 include the following steps: crushing the rhizome of Polygonatum cyrtonema, extracting it with warm water or hot water, centrifuging to remove the residue, precipitating the supernatant with ethanol of different concentrations in turn, centrifuging, and collecting the precipitate.
[0016] In the present invention, the step of extracting Polygonatum cyrtonema Graminans type fructan further comprises the following steps:
[0017] The powder of the rhizome of Polygonatum cyrtonema is extracted twice with hot water at a solid-liquid ratio of 1:8 to 1:12. Preferably, the solid-liquid ratio is 1:10.
[0018] Further, after centrifugation, ethanol with a final concentration of 35% to 45%, 55% to 65% and 75% to 85% is added to the supernatant for graded precipitation, and 55% to 65% alcohol precipitation is collected by centrifugation to obtain Polygonatum sibiricum Graminans type fructan. Preferably, the ethanol concentrations of the graded alcohol precipitations are 40%, 60% and 80% respectively.
[0019] In the present invention, the method for refining the Polygonatum cyrtonema rhizome glucomannan in step 3 is selected from one or more of graded alcohol precipitation, anion exchange chromatography, gel exclusion chromatography, dialysis and ultrafiltration. Preferably, one or more of gel exclusion chromatography, anion exchange chromatography and ultrafiltration.
[0020] According to the preparation method provided by the present invention, the obtained Polygonatum cyrtonema Graminans type fructan has a weight average molecular weight of 5kDa to 6kDa, and has a main chain of →6)-α-D-Glcp-(1→, →1)-β-D-Fruf-(2→ and →1,6)-β-D-Fruf-(2→, and β-D-Fruf-(2→) as side chains, contains acetyl groups, and is substituted at the 2nd, 3rd and 6th positions of the mannose residues, and →4)-β-D-Glcp-(1→, →4)-β-D-Manp-(1→, →4)-2-O-acetyl-β-D-Manp-(1→, →4)-3-O-acetyl-β-D-Manp-(1→ and →4)-6-O-acetyl-β-D-Manp-(1→) structural fragments may be connected to the side chains.
[0021] The Polygonatum cyrtonema Graminans-type fructan with a novel structure described in the present invention can significantly promote the secretion of cytokines such as IL-6 and TNF-α by RAW264.7 cells, thereby having the ability to regulate the body's immunity.
[0022] The present invention further provides a Polygonatum cyrtonema Graminans type fructan composition, which contains an effective amount of Polygonatum cyrtonema Graminans type fructan.
[0023] Furthermore, the composition also includes an effective amount of Polygonatum graminans type fructan and / or medicinal and / or food and / or cosmetic auxiliary materials or excipients or flavoring agents.
[0024] Furthermore, the Polygonatum cyrtonema Graminans type fructan and the composition thereof can be in the form of oral or parenteral administration. Specifically, the dosage form thereof can be capsules, lyophilized powders, oral liquids, cachets or tablets optionally containing Polygonatum cyrtonema Graminans type fructan as an active ingredient.
[0025] Furthermore, the Polygonatum graminans type fructan and the composition thereof can also be used topically, and can be made into dosage forms including but not limited to: facial mask, cream, ointment, gel, etc.
[0026] An application of the above-mentioned Polygonatum graminans type fructan or pharmaceutical composition in products for improving body immunity.
[0027] In the present invention, the dosage forms of the Polygonatum cyrtonema Graminans type fructan and the composition thereof include but are not limited to freeze-dried powder, oral liquid, capsule, tablet and the like.
[0028] In the present invention, the dosage form of the cosmetic can be selected from facial masks, gels, creams, ointments, and isolation agents.
[0029] In summary, due to the adoption of the above technical solution, the beneficial effects of the present invention are:
[0030] The Graminans-type fructan prepared by the present invention is reported for the first time. The inventor's cell experimental research has confirmed that it has the function of promoting macrophages to secrete cytokines and improving immunity, and has important potential for application as a health product or medicine.
[0031] The innovative method provided by the present invention is used to extract and purify the rhizome of Polygonatum cyrtonema, and a Polygonatum cyrtonema Graminans type fructan with a novel structure is obtained. Through further pharmacological activity studies, it is found that the newly discovered Polygonatum cyrtonema Graminans type fructan has the purpose of regulating immunity. Therefore, the Polygonatum cyrtonema Graminans type fructan with a novel structure, its preparation method and composition, and its application in the preparation of cosmetics and immunomodulatory drugs and / or foods provided by the present invention are all publicly reported for the first time. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] Figure 1 This is the molecular weight distribution curve of Polygonatum cyrtonema Graminans type fructan;
[0033] Figure 2A HPLC chart of monosaccharide composition of Graminans-type fructan derivatization of Polygonatum cyrtonema (A);
[0034] Figure 2B HPLC chart of monosaccharide composition of Graminans-type fructans from Polygonatum cyrtonema by direct analysis (B);
[0035] Figure 3 This is the total ion current diagram of methylation of Graminans-type fructan from Polygonatum cyrtonema;
[0036] Figure 4A One-dimensional NMR of Polygonatum cyrtonema Graminans-type fructan 1 H spectrum;
[0037] Figure 4B One-dimensional NMR of Polygonatum cyrtonema Graminans-type fructan 13 C spectrum;
[0038] Figure 4CGraminans type fructan 1 H- 13 C HSQC spectrum;
[0039] Figure 4D This is the DEPT-135 spectrum of Graminans-type fructan from Polygonatum cyrtonema;
[0040] Figure 5 Effects of Polygonatum graminans on RAW264.7 cell viability (A) Effects on macrophage NO release (B) Effects on IL-6 secretion from RAW264.7 cells (C) Effects on TNF-α secretion from RAW264.7 cells (D) In the figure, "*" represents significance compared with the blank group, * represents p<0.05, ** represents p<0.01, *** represents p<0.001, n=3.
[0041] Figure 6 The effect of Polygonatum graminans on NF-κB signaling pathway (A) Quantitative analysis of p-P65 / P65 (B) Quantitative analysis of p-IκBα / IκBα (C). In the figure, "*" represents significant difference compared with the blank group, * represents p<0.05, ** represents p<0.01, *** represents p<0.001, n=3. DETAILED DESCRIPTION
[0042] In order to facilitate the understanding of the present invention, the present invention will be described more comprehensively below, and preferred embodiments of the present invention are provided. However, the present invention can be implemented in many different forms and is not limited to the embodiments described in the present invention. On the contrary, the purpose of providing these embodiments is to make the understanding of the disclosure of the present invention more thorough and comprehensive.
[0043] Unless otherwise defined, all technical and scientific terms used in the present invention have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used in the specification of the present invention herein are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and / or" used in the present invention includes any and all combinations of one or more related listed items.
[0044] The Polygonatum cyrtonema Graminans type fructan of one embodiment of the present invention has a structure represented by the following general formula:
[0045]
[0046] In the chemical formula (1), n represents the number of sugar repeating units, and n is a natural number from 1 to 5; R represents an acetyl group (CH 3 CO-), the sugar to which it is attached is mannose.
[0047] The weight average molecular weight of the Polygonatum graminans type fructan is 5kDa to 6kDa, and it has a main chain of →6)-α-D-Glcp-(1→, →1)-β-D-Fruf-(2→ and →1,6)-β-D-Fruf-(2→, and a side chain of β-D-Fruf-(2→ and →6)-β-D-Fruf-(2→, and contains an acetyl group, and is substituted at the 2nd, 3rd and 6th positions of the mannose residue.
[0048] →4)-β-D-Glcp-(1→, →4)-β-D-Manp-(1→, →4)-2-O-acetyl-β-D-Manp-(1→, →4)-3-O-acetyl-β-D-Manp-(1→ and →4)-6-O-acetyl-β-D-Manp-(1→).
[0049] In a specific example, the weight average molecular weight of the Polygonatum cyrtonema Graminans type fructan is 5 kDa to 6 kDa, and the 2nd, 3rd or 6th position on the sugar ring of mannose is partially substituted by an acetyl group.
[0050] The method for preparing the above-mentioned Polygonatum cyrtonema Graminans type fructan according to an embodiment of the present invention comprises the following steps S1 to S3:
[0051] S1: extracting a crude polysaccharide solution from the rhizome of Polygonatum cyrtonema using warm water or hot water;
[0052] S2: graded alcohol precipitation to obtain crude polygonatum cyrtonema polysaccharide;
[0053] S3: purifying 60% of the alcohol precipitate in the crude Polygonatum cyrtonema polysaccharide to obtain the Polygonatum cyrtonema Graminans type fructan.
[0054] In a specific example, S1 includes the following steps: weighing dried rhizome powder of Polygonatum cyrtonema, adding 8 to 12 times of deionized water thereto, heating and extracting at 75 to 85° C. for 2 to 4 hours, extracting twice; centrifuging to obtain a supernatant.
[0055] Then, ethanol is added to the supernatant under stirring to a final concentration of 35% to 45%, and the mixture is centrifuged (4000rpm×10min) to obtain a 35% to 45% alcohol precipitate and a 35% to 45% alcohol precipitate supernatant; 95% ethanol is added to the 35% to 45% alcohol precipitate supernatant under stirring to a final alcohol concentration of 55% to 65%, and the mixture is centrifuged to obtain a 55% to 65% alcohol precipitate and an alcohol precipitate supernatant; the 55% to 65% alcohol precipitate is washed with 95% ethanol for 3 times, and the mixture is reconstituted with water and then freeze-dried; 95% ethanol is added to the 55% to 65% alcohol precipitate supernatant under stirring to a final alcohol concentration of 75% to 85%, and the mixture is centrifuged (4000rpm×10min) to obtain a 75% to 85% alcohol precipitate and an alcohol precipitate supernatant; the 75% to 85% alcohol precipitate is washed with 95% ethanol for 3 times, and the mixture is reconstituted with water and then freeze-dried to obtain crude Polygonatum cyrtonema Graminans type fructan.
[0056] The method for refining Yunnan Polygonatum Graminans type fructan is selected from one or more of anion exchange column chromatography, gel exclusion chromatography column method, dialysis method and ultrafiltration method. Specifically, the crude Yunnan Polygonatum Graminans type fructan component can be re-dissolved with deionized water, and a small amount of insoluble matter can be removed by centrifugation, and optionally purified by anion exchange column chromatography, gel exclusion chromatography, dialysis method or ultrafiltration method, and the flow fraction or retentate or permeate containing Yunnan Polygonatum Graminans type fructan is collected. If it contains salt, it needs to be desalted, and then directly freeze-dried in vacuum or concentrated under reduced pressure and then alcohol precipitated and dried under reduced pressure to obtain refined Yunnan Polygonatum Graminans type fructan.
[0057] It is easy for a person skilled in the art to understand that for gel exclusion chromatography, the gel material is reasonably selected according to the molecular weight of the polysaccharide substance in the Yunnan Polysaccharide component, such as the Sephadex series of dextran gel, the Sepharose series of agarose gel, the Bio-Gel P series of polyacrylamide, and the gel fillers formed by cross-linking them, and then the columns are loaded, the samples are loaded, and the elution solutions containing or not containing salt are used to elute and collect the flow fractions in sequence according to the actual performance of each filler. Anion exchange column chromatography is a separation technology based on the principle of ion exchange. Anion exchangers are usually positively charged and can bind to negatively charged components in the mixture. Relying on the attraction between particles with opposite charges, by changing the ionic strength and pH value of the flushing liquid, different substances are bound to different degrees with the chromatographic agent to achieve the purpose of separation. For example, DEAE-52 is loaded, the samples are loaded, and the elution solutions containing or not containing salt are used to elute and collect the flow fractions in sequence according to the actual performance of the filler. The effluent may be concentrated or not, and may be placed in a dialysis bag for dialysis or an ultrafiltration membrane bag for ultrafiltration desalination, and the retentate after desalination may be collected and subjected to vacuum freeze drying or vacuum decompression drying to obtain purified Polygonatum cyrtonema Graminans type fructan. Alternatively, when purifying Polygonatum cyrtonema polysaccharide components by dialysis or ultrafiltration, an ultrafiltration membrane bag of appropriate molecular weight may be selected for tangential flow ultrafiltration interception treatment. For example, the Polygonatum cyrtonema polysaccharide component aqueous solution is first fully ultrafiltered through an ultrafiltration membrane bag with a molecular weight greater than that of Polygonatum cyrtonema Graminans type fructan, and the permeate or effluent is collected to remove substances with high molecular weight, and then fully dialyzed or ultrafiltered through a dialysis bag or ultrafiltration membrane bag with a molecular weight less than that of Polygonatum cyrtonema Graminans type fructan, and the retentate is collected, concentrated, and subjected to vacuum freeze drying or vacuum decompression drying to obtain purified Polygonatum cyrtonema Graminans type fructan.
[0058] The present invention also provides a method for analyzing the structure of the above-mentioned Polygonatum cyrtonema Graminans type fructan, comprising the following steps:
[0059] (1) Molecular weight determination: Take a sample of Polygonatum cyrtonema Graminans type fructan and use high performance gel exclusion chromatography-differential detection method for detection.
[0060] (2) Analysis of monosaccharide composition: The monosaccharide composition of polysaccharides was analyzed by PMP derivatization combined with acid hydrolysis direct analysis. A sample of Polygonatum cyrtonema fructan was taken, acid hydrolyzed into monosaccharides, and derivatized with 1-phenyl-3-methyl-5-pyrazolone (PMP). The monosaccharide composition of Polygonatum cyrtonema fructan was analyzed by high performance liquid chromatography using a chromatographic column filled with octadecylsilane bonded silica gel; it was partially hydrolyzed into monosaccharides using a low concentration of acid, and then directly injected into a chromatographic column such as sugar-D, and the monosaccharide composition of Polygonatum cyrtonema fructan was analyzed by high performance liquid chromatography.
[0061] (3) Methylation analysis: Take a sample of Polygonatum cyrtonema-type fructan and use a methyl halide reagent such as iodomethane under alkaline conditions to methylate the polysaccharide. After hydrolysis under alkaline conditions, use sodium borohydride to reduce it, and use an acid anhydride to acetylate the methylated sugar alcohol. After extraction, use gas chromatography-mass spectrometry (GC-MS) analysis to determine the glycosidic bond connection mode of Polygonatum cyrtonema-type fructan.
[0062] (4) Nuclear magnetic resonance analysis: Take a sample of Polygonatum cyrtonema-type fructan and dissolve it in heavy water, freeze-dry it in a vacuum, repeat the heavy water exchange three times, and then dissolve it in heavy water. The nuclear magnetic resonance spectrum of the sample is tested, including one-dimensional 1 H. 13 C spectrum and two-dimensional 1 H- 1 H COSY, 1 H- 1 H TOCSY, 1 H- 1 H ROESY, 1 H- 13 C HSQC, 1 H- 13 C HMBC correlation spectrum.
[0063] (5) Comprehensive data analysis: Comprehensively analyze the analytical data of the above steps to analyze the chemical structure of Polygonatum cyrtonema Graminans-type fructan. According to the above structural analysis method, the Polygonatum cyrtonema Graminans-type fructan extracted and purified from Polygonatum cyrtonema using the preparation method of the present invention was subjected to structural analysis. The results showed that the Polygonatum cyrtonema Graminans-type fructan showed only one chromatographic peak with good symmetry on the HPGPC gel chromatography, and the weight-average molecular weight of the polysaccharide precipitated by 60% ethanol graded alcohol from Polygonatum cyrtonema was about 5341Da, and its polydispersity index was 1.77; the monosaccharide composition showed that the Polygonatum cyrtonema Graminans-type fructan was composed of fructose and glucose; the methylation analysis showed that the Polygonatum cyrtonema Graminans-type fructan had β(1→4) mannose glycosidic bonds and β(1→4) glucose glycosidic bonds; according to the NMR spectrum data, the Polygonatum cyrtonema Graminans-type fructan can be clearly attributed to 1 H and 13 C's signal.
[0064] Based on the above data, the Graminans type fructan has the structural characteristics shown in the following general formula: →6)-α-D-Glcp-(1→, →1)-β-D-Fruf-(2→ and →1,6)-β-D-Fruf-(2→ as the main chain, β-D-Fruf-(2→ and →6)-β-D-Fruf-(2→ as the side chain, containing acetyl groups, and substituted at the 2nd, 3rd and 6th positions of the mannose residues, →4)-β-D-Glcp-(1→, →4)-β-D-Manp-(1→, →4)-2-O-acetyl-β-D-Manp-(1→, →4)-3-O-acetyl-β-D-Manp-(1→ and →4)-6-O-acetyl-β-D-Manp-(1→ structural fragments may be connected to the side chain.
[0065]
[0066] In formula (1), n represents the number of sugar repeating units, and n is a natural number from 1 to 5; R represents an acetyl group (CH 3 CO-), the sugar to which it is attached is mannose.
[0067] The present invention surprisingly found through pharmacological research that the Polygonatum cyrtonema Graminans type fructan can activate macrophages, produce NO and release immune-related active substances such as cellular immune factors such as IL-6 and TNF-α, and has significant immunoregulatory activity.
[0068] To this end, the present invention also provides the use of the Polygonatum cyrtonema Graminans type fructan in the preparation of immunomodulatory drugs and / or foods.
[0069] The pharmaceutical composition of the embodiment of the present invention comprises the Polygonatum sibiricum Graminans type fructan or a pharmaceutically acceptable salt or a pharmaceutically acceptable solvate thereof, and pharmaceutically and / or food and / or cosmetically acceptable excipients. Optionally, the excipients include pharmaceutical excipients, carriers and / or diluents and / or film-forming agents, etc.
[0070] In a specific example, the dosage form of the above-mentioned pharmaceutical composition is an injection, a solid preparation or an oral solution, such as an aqueous injection, a lyophilized powder injection, a capsule, an oral solution, etc., and the auxiliary materials include excipients and / or flavoring agents, etc.
[0071] The cosmetic composition of the embodiment of the present invention comprises the Polygonatum sibiricum Graminans type fructan and its cosmetically acceptable salt or cosmetically acceptable solvate, and cosmetically acceptable excipients. Optionally, the excipients include cosmetic excipients, carriers and / or diluents / or film-forming agents, etc.
[0072] In a specific example, the dosage form of the above-mentioned cosmetics is a cream or a gel, and the auxiliary materials include excipients and / or diluents, etc.
[0073] The present invention is described in detail below with reference to specific embodiments in conjunction with the accompanying drawings. However, these embodiments do not constitute any limitation to the scope of the claims of the present invention.
[0074] Example 1 Extraction and purification of Polygonatum cyrtonema Graminans type fructan
[0075] 1. Extraction of Polygonatum odoratum Crude Polysaccharide
[0076] Weigh 300g of crushed Polygonatum sibiricum, place it in a three-necked bottle, add 3L of 95% ethanol (solid-liquid ratio 1:10, w / v), heat the three-necked bottle in a water bath, and soak it at 50℃ overnight. Filter the extract while hot, combine the filtrate, collect the residue, and naturally evaporate the residual ethanol in a ventilated place. Place the dried Polygonatum sibiricum powder after ethanol extraction in a three-necked bottle, add 3L of deionized water (solid-liquid ratio 1:10, w / v), extract it twice at 80℃ in a water bath, each time for 2h, cool to room temperature, combine the extracts, centrifuge (4000rpm, 15min, 20℃), add 95% ethanol to the supernatant to an alcohol concentration of 40%, centrifuge (4000rpm×20min), and obtain 40% alcohol precipitate and 40% alcohol precipitate supernatant; add 95% ethanol to the above 40% alcohol precipitate supernatant under stirring to an alcohol concentration of 60%, centrifuged (4000rpm×20min), to obtain 60% alcohol precipitate and alcohol precipitate supernatant; to the above 60% alcohol precipitate supernatant, 95% ethanol was added under stirring to an alcohol concentration of 80%, centrifuged (4000rpm×20min), to obtain 80% alcohol precipitate, 40%, 60% and 80% alcohol precipitates were washed once with 95% ethanol, 40%, 60% and 80% alcohol precipitates were washed once with anhydrous ethanol, the precipitates after centrifugation were re-dissolved in water and freeze-dried to obtain 53.56g of crude Polygonatum cyrtonema Graminans type fructan.
[0077] 2. Refining of Graminans-type fructan from Polygonatum cyrtonema
[0078] Weigh about 300 mg of the crude Polygonatum cyrtonema Graminans fructan, dissolve it in 8 mL of deionized water, centrifuge (8000 rpm × 20 min), filter the supernatant through a 0.22 μm filter membrane, and slowly and evenly inject it into the top of a weak anion exchange gel column. Elute with 3 times the column volume of deionized water, and collect the flow-through.
[0079] (2) Gel column chromatography: Add the flow-through liquid to a Sephadex G-75 gel chromatography column, use 0.1M NaCl solution as the mobile phase for elution, elute for at least 3 column volumes, collect the flow-through liquid, control the flow rate to 1mL / min, collect 5mL in each tube, and detect its polysaccharide content using the phenol-sulfuric acid method. Draw the elution curve of the polysaccharide component with the absorbance value as the ordinate and the number of tubes as the abscissa. Combine the eluates belonging to the same elution peak, collect the sample with the largest area of the elution curve, dialyze for 48h using a dialysis bag (MWCO 1000Da), and freeze-dry to obtain the refined Yunnan Polygonatum Graminans-type fructan.
[0080] Example 2 Structural analysis of Polygonatum cyrtonema Graminans type fructan
[0081] 1. Experimental Methods
[0082] 1.1. Molecular weight and its distribution
[0083] The molecular weight and distribution of the Polygonatum cyrtonema Graminans type fructan prepared in Example 1 were analyzed by high performance gel exclusion chromatography-differential detection detection (HPGPC-RID).
[0084] Chromatographic instrument: Agilent technologies 1260 series high performance liquid chromatograph;
[0085] Chromatographic conditions: Shodex OHpak SB-804HQ (8 mm × 300 mm) column; column temperature, 35 °C; differential detector; mobile phase, 0.1 M NaCl, flow rate, 0.5 mL / min;
[0086] Determination process: Take 1 mg of Graminans-type fructan sample or dextran reference substance with known molecular weight and add mobile phase to prepare a 1 mg / mL solution, pass through a 0.2 μm microporous filter membrane, and analyze 30 μL of the filtrate in a high-performance liquid chromatograph to record the chromatogram. The data is processed using GPC software, a standard curve is drawn, and the data is entered into the equation to calculate the molecular weight.
[0087] 1.2 Monosaccharide composition analysis
[0088] The monosaccharide composition of polysaccharides was analyzed by PMP derivatization method combined with acid hydrolysis direct analysis method.
[0089] PMP derivatization method: Take 1 mL of sample solution and monosaccharide mixed standard solution in a COD tube, add 1 mL of 4MTFA solution, hydrolyze at 110℃ for 4h, take out, cool to room temperature, spin dry, add 2 mL of methanol and spin dry again (repeat 3 times) until there is no sour taste of TFA. Add 200 μL of deionized water to the residue of sample solution and monosaccharide mixed standard solution, then add 200 μL of 0.6M NaOH solution and 400 μL of 0.5M PMP methanol solution, mix well and place at 70℃ for 1h, take out, cool to room temperature, add 200 μL of 0.6M HCl solution, add 2 mL of chloroform, shake vigorously, stand, and discard the lower layer of liquid (repeat 3 times). The upper layer of liquid is placed in a 1.5 mL centrifuge tube, centrifuged (13000 rpm, 10 min, 20℃), filtered through a 0.2 μm microporous filter membrane, and analyzed in a high performance liquid chromatograph.
[0090] Chromatographic conditions:
[0091] Instrument: Agilent technologies 1260 series high performance liquid chromatograph;
[0092] Chromatographic column: XSelect HSS T3 (4.6×250mm, 5μm); column temperature: 25℃;
[0093] Mobile phase: 0.1 M phosphate buffer (pH 6.8): acetonitrile (82:18);
[0094] Flow rate: 1 mL / min; injection volume 10 μL; time 60 min;
[0095] Detection: DAD detector, wavelength 250nm.
[0096] Acid hydrolysis direct analysis method: Take the sample and the monosaccharide mixed standard in a COD tube, add 1mL 0.5M TFA to dissolve it, place it at 100℃ for 2h, take it out, cool it to room temperature, spin dry it, add 2mL methanol and spin dry it again (repeat the operation 3 times) until there is no sour smell of TFA. Add 1mL deionized water to dissolve the residue, place it in a 1.5mL centrifuge tube, centrifuge (13000rpm, 10min, 20℃), filter it through a 0.2μm microporous filter membrane, and analyze it in a high performance liquid chromatograph.
[0097] Instrument: Agilent technologies 1260 series high performance liquid chromatograph;
[0098] Chromatographic column: Cosmosil Sugar-D (4.6×250mm, 5μm); column temperature: 30℃;
[0099] Mobile phase: water:acetonitrile (15:85);
[0100] Flow rate: 0.2 mL / min; injection volume 1 μL; time 30 min;
[0101] Detection: Refractive Index Detector (RID).
[0102] 1.3 Methylation analysis
[0103] (1) Methylation reaction
[0104] Weigh 3 mg of polysaccharide sample into a COD tube, add 1 mL of DMSO to dissolve it, then add 1 mL of 50 mg / mL NaOH / DMSO suspension (prepared in advance), stir evenly, add 1 mL of iodomethane dropwise under closed and ice bath conditions, stir for 2 hours, and add 1 mL of deionized water to stop the reaction. Then add 2 mL of chloroform for extraction (repeat 3 times), take the chloroform layer, add 2 mL of deionized water to extract again (repeat 3 times), and spin dry the chloroform.
[0105] (2) Acid hydrolysis
[0106] Add 2 mL of 0.5 M TFA to the residue, hydrolyze at 70 °C for 3 h, take out, cool to room temperature, spin dry, add 2 mL of methanol and spin dry again (repeat 3 times) until the sour smell of TFA disappears.
[0107] (3) Restore
[0108] Add 1 mL of deionized water to the residue, add 1 M NaOH solution to make the pH reach 10, and then add 15 mg of NaBD 4 The solid was stirred at 50°C for 2 h, then 500 μL of glacial acetic acid was added and the mixture was spin-dried.
[0109] (4) Acetylation of sugar alcohols
[0110] Add 1 mL of pyridine and 1 mL of acetic anhydride to the residue, react at 100°C for 1 h, and add 1 mL of deionized water to stop the reaction. Add 2 mL of dichloromethane to extract (repeat 3 times), add 2 mL of deionized water to extract again (repeat 3 times), and spin dry the dichloromethane layer. Add 1 mL of dichloromethane, place in a 1.5 mL centrifuge tube, centrifuge (13000 rpm, 10 min, 20°C), and then filter through a 0.2 μm microporous membrane and analyze by GC-MS.
[0111] (5) GC conditions
[0112] Instrument: Agilent Technologies 7890A gas chromatograph; Chromatographic column: DB-5MS quartz capillary column (30m×0.25mm×0.25μm); Injection volume: 1μL; Injection port temperature: 250℃; Carrier gas: high-purity helium; Column flow rate: 1.5mL / min;
[0113] GC conditions: DB-5MS quartz capillary column (30m×0.25mm×0.25μm); column temperature: initial temperature 80℃, hold for 1min, program temperature rise 5℃ / min to 250℃, hold for 5min; column flow rate 1.5mL / min; injection port temperature 270℃; split ratio 10:1; carrier gas is high-purity helium, injection volume 1μL.
[0114] MS conditions: ionization mode EI; electron energy 70 eV; transfer line temperature 290 °C; ion source temperature 230 °C; quadrupole temperature 150 °C; mass range 50-600; compared with the CCRC spectral database to determine the glycosidic bond type.
[0115] 1.4 Nuclear magnetic resonance analysis
[0116] Take 20 mg of Polygonatum cyrtonema Graminans type fructan sample and dissolve it in 1 mL D 2 O, freeze-dried, D 2 After three exchanges of O, the freeze-dried sample was dissolved in 0.5 mL D 2 O(99.9atom%D, containing internal standard 0.05wt.%3-(trimethylsilyl)propionic-2,2,3,3-d 4 Acid, sodium salt). Measured using a Bruker 800MHz NMR spectrometer 1 H / 13 C NMR spectra and 2D spectra 1 H- 1 H COSY, 1 H- 1 H TOCSY, 1 H- 1 HROESY, 1 H- 13 C HMBC and 1 H- 13 CHSQC, using MestReNova software for analysis and processing.
[0117] 2. Experimental results
[0118] The properties of the Polygonatum cyrtonema Graminans type fructan of the invention are: white or yellowish white solid, tasteless, easily soluble in water and hygroscopic.
[0119] The results of high performance gel exclusion chromatography showed that (Appendix Figure 1 ), the Graminans-type fructan extracted and purified from Polygonatum sibiricum has only one symmetrical chromatographic peak, with a weight-average molecular weight (Mw) of 5371 Da and a polydispersity coefficient of 1.77.
[0120] The results of monosaccharide composition analysis showed that (Appendix Figure 2A and 2B ), the Polygonatum cyrtonema Graminans type fructan
[0121] The HPLC chart after PMP pre-column derivatization combined with acid hydrolysis direct analysis showed characteristic peaks of glucose and fructose.
[0122] It is explained that the monosaccharide composition of the Polygonatum cyrtonema Graminans type fructan contains glucose and fructose.
[0123] The results of methylation analysis showed that (Appendix Figure 3 ), the Graminans-type fructan has α(1→6) glucose glycosidic bonds, β(1→2) fructose glycosidic bonds, β(2→6) fructose glycosidic bonds, β(1,2→6) fructose glycosidic bonds and β(1→) fructose glycosidic bonds.
[0124] Some results of NMR analysis are attached. Figure 4A , 4B , 4C, 4D, detailed 1 H and 13 The assignment of CNMR signals is shown in Tables 1 and 2. 1 The terminal hydrogen signal (δ H 5.42) and 13 The four terminal carbon signals (approximately δ C 106.0-107.0), combined with the results of monosaccharide composition analysis and methylation analysis, this is a typical characteristic peak of fructan; in the DEPT 135 spectrum, δ C The absence of a peak at 106.0-107.0 also indicates that this is a quaternary carbon signal. C There is no cross peak at 106.0-107.0, which indicates that it is fructan. H 4.19-4.24 should be attributed to the 3-position hydrogen signal of fructose residue; δ H 4.07-4.12 should be attributed to the hydrogen signal at position 4 of the fructose residue; δ C 106.0-107.0 should be attributed to the 2-carbon signal of the fructose residue, which also suggests that the fructose residues are all in β configuration; δ C79.41-79.90 should be attributed to the 3-carbon signal of the fructose residue; δ C 77.26-77.81 should be attributed to the carbon 4 signal of fructose residue; δ C 83.13-84.08 should be attributed to the carbon 5 signal of the fructose residue. According to the methylation analysis results, residues A, B, C and D should be attributed to β-D-Fruf-(2→, →6)-β-D-Fruf-(2→, →1)-β-D-Fruf-(2→ and →1,6)-β-D-Fruf-(2→, respectively. Residue E: δ H 5.42 and δ C The weak terminal signal at 95.04 is attributed to the sugar residue with relatively low content, which also indicates that residue E is in α configuration. Based on the methylation analysis results, it can be inferred that residue E is →6)-α-D-Glcp-(1→.
[0125] exist 1 H NMR spectra and in δ C 22.91-23.41 and δ C 175.58-176.81 13 The C NMR spectrum inferred that it contained acetyl groups, and the acetyl groups were substituted at different positions. In the HSQC spectrum, the terminal group signal δ H 4.77 / δ C 103.27, δ H 4.95 / δ C 102.12 and δ H 4.83 / δ C 102.66 should be attributed to the mannose residue. In addition, the cross peak signal δ H 4.53 / δ H 4.28 / δ C 65.89 also belongs to the H6 / C6 position of the mannose residue, which is marked as G, H, I, and J. δ H
[0126] 4.50 / δ C 105.64 should be attributed to other sugar residues, labeled F. Other residues F, G, H, I, and J 1 H and the corresponding 13 The C signals were assigned by COSY and HSQC spectra.
[0127] Based on the above data, it can be seen that the chemical structure of this novel Polygonatum cyrtonema Graminans-type fructan is shown in the following general formula.
[0128]
[0129] In the chemical formula (1), n represents the number of sugar repeating units, and n is a natural number from 1 to 5; R represents an acetyl group (CH 3 CO-), the sugar to which it is attached is mannose.
[0130] Its structural characteristics are as follows: (1) the Yunnan Polygonatum Graminans type fructan is a novel fructan extracted from the rhizome of Yunnan Polygonatum; (2) it has →6)-α-D-Glcp-(1→, →1)-β-D-Fruf-(2→ and →1,6)-β-D-Fruf-(2→ as the main chain, β-D-Fruf-(2→ and →6)-β-D-Fruf-(2→ as the side chain, contains acetyl groups, and is substituted at the 2nd, 3rd and 6th positions of the mannose residues, contains acetyl groups, and is substituted at the 2nd, 3rd and 6th positions of the mannose residues. The structural fragments of the present invention may be connected to the side chain. According to the search of domestic and foreign public literature, this arrangement and chemical structure of the Polygonatum cyrtonema Graminans type fructan have not been publicly reported, and are discovered by the inventors for the first time.
[0131] Table 1. Graminans-type fructans 1 Assignment of H NMR
[0132]
[0133]
[0134] Table 2. Polygonatum cyrtonema Graminans type fructans 13 Assignment of C NMR
[0135]
[0136] Example 3 Experiment on the immunoenhancing activity of Polygonatum cyrtonema Graminans type fructan
[0137] 1. Test articles, reagents and cells
[0138] Polygonatum graminans type fructan, referred to as BSP60, was prepared according to Example 1. Fetal bovine serum, high glucose medium, penicillin-streptomycin, Nice Scientific Co., Ltd.; dimethyl sulfoxide, thiazolyl blue (MTT), lipopolysaccharide (LPS), Beijing Solebow Biotechnology Co., Ltd.; IL-6, IL-1β kits, Hangzhou Lianke Biotechnology Co., Ltd.; TNF-α kits, Xinbosheng Biotechnology Co., Ltd.; NO kits, Beyotime Biotechnology Co., Ltd. RAW264.7 cells were purchased from the Cell Resource Center of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.
[0139] 2. Experimental Methods
[0140] 2.1 Removal of LPS from samples
[0141] (1) Activate the Detoxi-GelTM Endotoxin Removing gel column with 5 resin bed volumes of 1% sodium deoxycholate, and then regenerate the detoxifying gel resin by washing with 10 resin bed volumes of sterile water for injection to remove the detergent. Regenerate the resin before each use.
[0142] (2) Equilibrate the detoxified gel resin with 5 resin bed volumes of sterile water for injection.
[0143] (3) Weigh a sample of Polygonatum cyrtonema-type fructan and dissolve it in sterile water for injection. Add the sample to the column and start collecting the sample. After the sample enters the column material, add an aliquot of pyrogen-free buffer or water, stop the column flow, incubate for 1 hour, collect the mobile phase, add 1 mL of sterile water for injection, and collect the mobile phase.
[0144] (4) freeze-drying to obtain Polygonatum cyrtonema Graminans type fructan (PKP for short) with LPS removed.
[0145] 2.2 RAW264.7 cell recovery
[0146] Take out the frozen RAW264.7 macrophages from the liquid nitrogen tank and place them in 37°C warm water prepared in advance to allow the cells to thaw and return to room temperature within 1 to 2 minutes. Then, transfer the cells to a 15 mL centrifuge tube, add 3 mL of DMEM medium, centrifuge at 1000 r / min for 3 minutes, discard the supernatant, add 2 mL of DMEM complete medium to blow the cells, and then transfer to a 10 cm 2 Place the cells in a culture dish and add 10 mL of culture medium to the dish. Shake the dish evenly. Observe the cell status and density under a microscope and place the cells in a cell culture incubator.
[0147] 2.3 RAW264.7 cell culture
[0148] After recovery, RAW264.7 macrophages were cultured in DMEM complete medium containing 10% fetal bovine serum (FBS) and 1% penicillin / streptomycin in a cell culture incubator at 37°C and 5% CO. 2 When the revived cells grow to 80% to 90% confluence, cell subculture is performed.
[0149] 2.4 Effects on macrophage viability
[0150] The CCK-8 method was used to evaluate the effect of Polygonatum graminans on the viability of RAW264.7 cells. 4 The cells were seeded at a density of 10 cells / well in a 96-well plate under 5% CO 2 After culturing in a cell culture incubator at 37°C for 24 hours, the culture medium was discarded and the cells were washed three times with PBS. Fresh serum-free culture medium containing various concentrations of PKP (50 μg / mL, 150 μg / mL and 450 μg / mL) was added to each well, and 1 μg / mL of LPS was used as a positive control. The cells were cultured for another 24 hours. 10 μL of CCK-8 solution was added to each well and incubated in an incubator in the dark for 2 hours. After the incubation, the OD value at 450 nm was immediately measured with an enzyme reader. Three replicate wells were set for each sample.
[0151] 2.5 Effects of Polygonatum graminans on the secretion of NO, IL-6 and TNF-α by macrophages
[0152] RAW264.7 cells were cultured at 1×10 5 The cells were seeded at a density of 10 cells / well in a 24-well plate under 5% CO 2 , and cultured in a cell culture incubator at 37°C for 24 h. Fresh serum-free culture medium containing various concentrations of PKP (450 μg / mL, 150 μg / mL, and 50 μg / mL) was added to each well. 1 μg / mL of LPS was used as a positive control. After culturing for 24 h, the culture supernatant was collected, and the NO content in the supernatant was detected by Griess method, and the secretion of IL-6 and TNF-α in the supernatant was detected by ELISA.
[0153] 2.6 Effects of Polygonatum graminans on NF-κB signaling pathway
[0154] RAW264.7 cells were seeded in 6-well plates at a density of 1106 cells / well and cultured in a cell culture incubator at 5% CO2 and 37°C for 24 hours. Fresh serum-free medium containing various concentrations of PKP (450μg / mL, 150μg / mL and 50μg / mL) was added to each well, and 1μg / mL of LPS was used as a positive control. After 24 hours of culture, total cell protein was extracted for protein quantification and normalization. Proteins were separated using 10% SDS-PAGE gel, transferred to activated PVDF membranes, blocked with 5% BSA for 2 hours, and then incubated with the corresponding primary antibodies p-P65 (1:1000), P65 (1:1000), p-IκBα (1:1000), IκBα (1:1000) and GAPDH (1:30000) at 4°C overnight; secondary antibodies were incubated at room temperature for 1 hour. The protein bands were developed using ECL luminescent solution, and the grayscale analysis of the protein bands was performed using ImageJ software.
[0155] 3. Experimental results
[0156] 3.1 Effects on macrophage viability
[0157] like Figure 5 As shown in A, PKP had no significant inhibitory effect on the proliferation of RAW264.7 cells, but PKP (450 μg / mL, 150 μg / mL and 50 μg / mL) could significantly promote the proliferation of RAW264.7 cells.
[0158] 3.2 Effects on NO, IL-6 and TNF-α secretion in RAW264.7 cells
[0159] As attached Figure 5 As shown in the figure, compared with the blank control group, LPS and PKP (450 μg / mL and 150 μg / mL) treatment can significantly promote the release of NO by RAW264.7. PKP promotes the secretion of IL-6 and TNF-α in a dose-dependent manner and has significant immunoenhancing activity.
[0160] 3.3 Effects on NF-κB signaling pathway
[0161] As attached Figure 5 As shown in the figure, compared with the control group, the expression of P65 and IκBα did not change significantly after PKP treatment, and 450μg / mL PKP and LPS could significantly promote the phosphorylation level of P65 and IκBα protein levels. PKP can promote the phosphorylation of P65 and IκBα and the secretion of NO, IL-6 and TNF-α by activating the NF-κB signaling pathway, thereby enhancing immune activity.
[0162] Example 4 Preparation of Polygonatum graminans type fructan capsules
[0163] 1. Materials
[0164] The Polygonatum cyrtonema Graminans type fructan and food or pharmaceutical grade starch are obtained in the same manner as in Example 1.
[0165] 2. Prescription
[0166]
[0167]
[0168] 3. Preparation process
[0169] Weigh the prescribed amount of Yunnan Polygonatum graminans type fructan and starch, stir to mix completely, add appropriate amount of talcum powder, wet granulate with ethanol, sieve and dry, and then put into No. 2 capsule shells, each capsule body is filled with 80 mg of Yunnan Polygonatum graminans type fructan, and Yunnan Polygonatum graminans type fructan capsules are prepared.
[0170] Example 5 Preparation of Polygonatum sibiricum Graminans Type Fructans Oral Liquid
[0171] 1. Materials
[0172] The Yunnan Polygonatum graminans type fructans obtained by the method of Example 1, and the food or pharmaceutical grade flavoring agents are and caramel flavor.
[0173] 2. Prescription
[0174] Name of raw materials Dosage Polygonatum sibiricum Graminans type fructan 50g sucrose 0.6g Caramel flavor 0.1g Purified water 2000mL Made in total 500 pieces
[0175] 3. Preparation process
[0176] Weigh the prescribed amount of Yunnan Polygonatum graminans type fructan, sucrose and caramel essence, add purified water to completely dissolve, filter through a 0.22 μm microporous filter membrane, and fill the filtrate into 4 mL per bottle through an oral liquid filling machine, seal and sterilize to obtain the product.
[0177] Example 6 Preparation of Polygonatum graminans type fructan gel
[0178] 1. Materials
[0179] The Polygonatum cyrtonema Graminans type fructan obtained by the same method as in Example 1 uses cosmetic grade or food grade raw materials.
[0180] 2. Prescription
[0181]
[0182]
[0183] 3. Preparation process
[0184] Weigh the prescribed amount of Polygonatum cyrtonema Graminans type fructan, add 5L of water to dissolve and set aside; sprinkle the prescribed amount of Carbomer 940 powder evenly on the surface of the glycerin to fully moisten the Carbomer, add 4L of water to fully swell the Carbomer, then add the pre-dissolved polysaccharide solution, stir and mix evenly to obtain a mixed solution I; dissolve ethylparaben in propylene glycol, and slowly add the mixed solution I to obtain a mixed solution II; then dissolve the prescribed amount of Polysorbate 80 and triethanolamine in 1L of water, add the mixed solution II under stirring, stir evenly, and can the Polygonatum cyrtonema Graminans type fructan gel.
[0185] Example 7 Preparation of Polygonatum sibiricum Graminans Type Freeze-dried Powder Injection
[0186] 1. Materials
[0187] The same method as in Example 1 was used to obtain the Polygonatum sibiricum Graminans type fructan and pharmaceutical grade sodium chloride.
[0188] 2. Prescription
[0189] Name of raw materials Dosage Polygonatum sibiricum Graminans type fructan 50g Sodium chloride 4.5g Water for injection 500mL Made in total 1000 pieces
[0190] 3. Preparation process
[0191] Weigh the prescribed amount of Polygonatum sibiricum Graminans type fructan and sodium chloride, add water for injection to the full amount, stir to dissolve completely, and sterilize by intermittent hot pressing. Add 0.3% medicinal activated carbon and stir for 20 minutes; use a Buchner funnel and a 3.0μm microporous filter membrane to remove the heat source by decarbonization filtration. After the content is qualified, filter with a 0.22μm microporous filter membrane; distribute into controlled vials, 0.5mL per bottle, half-stopper, place in a freeze drying oven, and freeze-dry according to the set freeze-drying curve,
[0192] The products are plugged, unpacked, capped, visually inspected and packaged to obtain the finished products.
[0193] Freeze-drying process: put the sample into the box, lower the partition temperature to -40℃, keep it for 4 hours; lower the cold trap to -50℃, and start to evacuate to 250μbar. Start sublimation: uniformly increase the temperature to -20℃ in 1 hour, keep it for 3 hours; uniformly increase the temperature to -10℃ in 3 hours, keep it for 8 hours, and keep the vacuum at 100~250μbar; then dry: increase the temperature to -5℃ in 2 hours, keep it for 2 hours, and keep the vacuum at 150~200μbar; increase the temperature to 10℃ in 0.5 hours, keep it for 2 hours, and keep the vacuum at 80~100μbar; increase the temperature to 40℃ in 0.5 hours, keep it for 4 hours, and evacuate to the lowest vacuum.
[0194] Example 8 Preparation of Polygonatum graminans type fructan facial cleanser
[0195] 1. Materials
[0196] The Polygonatum cyrtonema Graminans type fructan obtained by the same method as in Example 1 uses cosmetic grade or food grade raw materials.
[0197] 2. Formulation
[0198] Graminans type fructan 0.5g, glycerin 3.0g, butylene glycol 3.0g, propylene glycol 0.6g, sodium EDTA 0.1g, guar gum 0.3g, zinc dioxide 2.0g, C12-15 alcohol benzoate 4.0g, C12-20 alkyl glucoside 3.0g, C14-22 alcohol 0.5g, cetearyl alcohol 1.2g, paraben 0.2g, sodium stearate 0.3g, dimethicone 0.5g, polysorbate 0.2g, and deionized water 60g.
[0199] 3. Preparation process
[0200] Weigh the amount of Yunnan Polygonatum Graminans fructan, add purified water to completely dissolve; take glycerol, butylene glycol, propylene glycol, sodium EDTA, guar gum, zinc dioxide, sodium stearate, C12-15 benzoate, C12-20 alkyl glucoside, C14-22 alcohol, cetearyl alcohol, add purified water to mix; take paraben, polydimethylsiloxane alcohol, polysorbate, add purified water to mix. Mix the above prepared solutions, stir well, and can.
[0201] Example 9 Preparation of Polygonatum graminans type fructan facial mask
[0202] 1. Materials
[0203] The Polygonatum cyrtonema Graminans type fructan obtained by the same method as in Example 1 uses cosmetic grade or food grade raw materials.
[0204] 2. Prescription
[0205] Graminans type fructan 12g, transparent xanthan gum 3.5g, hydrolyzed hyaluronic acid 2.0g, sodium hyaluronate 2.0g, propylene glycol 0.3g, carbomer 0.5g, paraben 0.1, PPG-10 methyl glucose ether 0.25g, glyceryl glucoside 1.0g, deionized water 45g.
[0206] 3. Mask preparation process
[0207] Step 1. Add deionized water, transparent xanthan gum, hydrolyzed hyaluronic acid, sodium hyaluronate, propylene glycol, carbomer, and paraben into an emulsifying pot and heat to 75°C while stirring. After reaching the temperature, keep warm and continue stirring until the solution is transparent and uniform. Then keep warm for 20 minutes and then cool to 42°C.
[0208] Step 2: Adjust pH to 7.6 ± 0.2.
[0209] Step 3, continue to cool to 35°C, add PPG-10 methyl glucose ether, Polygonatum graminans type fructan, glycerol glucoside, continue to stir evenly, and discharge after passing the inspection. Coating is performed on a non-woven fabric substrate, with a coating amount of 2.1 g per square centimeter.
[0210] The descriptions of each patent, patent application and publication cited in this application are all incorporated into this application by reference. Any reference cited should not be considered as allowing these references to be used as "prior art" of this application.
[0211] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0212] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.
Claims
1. Graminans type fructan from Polygonatum sibiricum, It is characterized in that The Polygonatum cyrtonema Graminans type fructan has a structure represented by the following general formula: In formula (1), n represents the number of sugar repeating units, and n is a natural number from 1 to 5; R represents an acetyl group (CH 3 CO-), the sugar to which it is attached is mannose.
2. The Polygonatum graminans type fructan according to claim 1, It is characterized in that The weight average molecular weight of the Polygonatum cyrtonema Graminans type fructan is 5kDa-6kDa, and the 2nd, 3rd or 6th position of the mannose sugar ring is partially substituted by acetyl.
3. The Polygonatum cyrtonema Graminans type fructan according to claim 1, It is characterized in that The Graminans-type fructan is obtained by extraction and purification from the rhizome of Polygonatum kingianum of the Liliaceae family.
4. A method for preparing the Polygonatum cyrtonema Graminans type fructan according to any one of claims 1 to 3, It is characterized in that The following steps are involved: Step 1: extracting a crude polysaccharide solution from the rhizome of Polygonatum cyrtonema with warm water or hot water; Step 2: graded alcohol precipitation to obtain crude polygonatum odoratum polysaccharide; Step 3: purify 60% of the alcohol precipitate in the crude Polygonatum cyrtonema polysaccharide to obtain the Polygonatum cyrtonema Graminans type fructan.
5. The method for preparing the Polygonatum cyrtonema Graminans type fructan according to claim 4, It is characterized in that Step 1 and step 2 include the following steps: crushing the rhizome of Polygonatum cyrtonema, extracting it with warm water or hot water, centrifuging to remove the residue, and then using ethanol to grade the supernatant to precipitate Polygonatum cyrtonema polysaccharide so that its alcohol concentration reaches 40%, 60% and 80% respectively, and collecting the precipitate by centrifugation.
6. The method for preparing the Polygonatum graminans type fructan according to claim 4, It is characterized in that Step 3: The method for refining the Polygonatum cyrtonema Graminans type fructan is selected from one or more of the following methods: graded alcohol precipitation, anion exchange column chromatography, gel exclusion chromatography, dialysis and ultrafiltration.
7. A composition containing the Polygonatum cyrtonema Graminans type fructan according to any one of claims 1 to 3, It is characterized in that The composition comprises an effective amount of Polygonatum cyrtonema Graminans type fructan and / or pharmaceutical adjuvants or excipients or flavoring agents.
8. Use of the Polygonatum cyrtonema Graminans type fructan according to any one of claims 1 to 3 or the composition according to claim 7 in the preparation of drugs or foods for regulating immune activity.
9. Use of the Polygonatum graminans type fructan according to any one of claims 1 to 3 or the composition according to claim 7 in the preparation of cosmetics.
